The Technical AnalystExchange: TAI Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
YungShin Global Holding Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.10% TWD49.55
America/New_York / 3 mai 2024 @ 01:30
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 14 385 mill |
| EPS: | 3.11 |
| P/E: | 15.93 |
| Earnings Date: | May 09, 2024 |
| SharesOutstanding: | 290.31 mill |
| Avg Daily Volume: | 0.326 mill |
| RATING 2024-05-03 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.86x |
| Company: PE 15.93 | sector: PE 18.55 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.33x |
| Company: PE 15.93 | industry: PE 11.99 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
TWD90.02 (81.68%) TWD40.47 |
| Date: 2024-05-04 |
| Expected Trading Range (DAY) |
|---|
|
TWD 49.09 - 50.01 ( +/- 0.93%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | TWD49.55 (0.10% ) |
| Volume | 0.357 mill |
| Avg. Vol. | 0.326 mill |
| % of Avg. Vol | 109.45 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 3705.TW
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
3705.TW
YungShin Global Holding Corporation, through its subsidiaries, engages in the investment, manufacture, and sale of medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics in Taiwan, Mainland China, Japan, and the United States. The company engages in the extraction, manufacture, and sale of wood products; manufacture and sale of over-the-counter drugs, preparations, and chemical intermediates; and pharmaceutical research, transfer, authorization, and outsourcing of services, as well as import and export trading. In addition, it is involved in the trading, wholesale, and retail of health products, cosmetics, medicines, human testing reagents, and the aforesaid related raw materials; semi-finished products; and production equipment. The company was founded in 1952 and is based in Taichung, Taiwan.